天臣医疗（688013）1月5日主力资金净卖出170.80万元

Core Insights - Tianchen Medical (688013) closed at 51.22 yuan on January 5, 2026, with a 6.53% increase and a turnover rate of 3.26% [1] - The company reported a net outflow of 1.708 million yuan from main funds, while retail investors saw a net inflow of 597,400 yuan [1] Financial Performance - For the first three quarters of 2025, Tianchen Medical achieved a main revenue of 244 million yuan, a year-on-year increase of 20.66% [3] - The net profit attributable to shareholders reached 71.9458 million yuan, up 68.29% year-on-year, with a non-recurring net profit of 66.2023 million yuan, increasing by 71.85% [3] - In Q3 2025, the company reported a quarterly main revenue of 87.6631 million yuan, a 26.4% year-on-year increase, and a quarterly net profit of 23.7342 million yuan, up 70.74% [3] - The company's debt ratio stands at 11.3%, with an investment income of 2.556 million yuan and financial expenses of -10.8703 million yuan, resulting in a gross profit margin of 63.22% [3] Financing and Margin Information - On January 5, 2026, Tianchen Medical had a financing buy of 10.4463 million yuan and a financing repayment of 14.4032 million yuan, resulting in a net repayment of 3.9569 million yuan [2] - The company has a financing and margin balance of 2.12 billion yuan [2]